94 related articles for article (PubMed ID: 9987657)
1. Etoposide sensitivity of human prostatic cancer cell lines PC-3, DU 145 and LNCaP.
Salido M; Larrán J; López A; Vilches J; Aparicio J
Histol Histopathol; 1999 Jan; 14(1):125-34. PubMed ID: 9987657
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptides bombesin and calcitonin induce resistance to etoposide induced apoptosis in prostate cancer cell lines.
Salido M; Vilches J; López A
Histol Histopathol; 2000 Jul; 15(3):729-38. PubMed ID: 10963117
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status.
Serafin AM; Akudugu JM; Bohm L
Urol Res; 2002 Oct; 30(5):289-94. PubMed ID: 12389116
[TBL] [Abstract][Full Text] [Related]
4. Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells.
Berchem GJ; Bosseler M; Sugars LY; Voeller HJ; Zeitlin S; Gelmann EP
Cancer Res; 1995 Feb; 55(4):735-8. PubMed ID: 7850782
[TBL] [Abstract][Full Text] [Related]
5. X-ray microanalysis of etoposide-induced apoptosis in the PC-3 prostatic cancer cell line.
Salido M; Vilches J; Lopez A; Roomans GM
Cell Biol Int; 2001; 25(6):499-508. PubMed ID: 11407855
[TBL] [Abstract][Full Text] [Related]
6. Adrenomedullin prevents apoptosis in prostate cancer cells.
Abasolo I; Montuenga LM; Calvo A
Regul Pept; 2006 Jan; 133(1-3):115-22. PubMed ID: 16297990
[TBL] [Abstract][Full Text] [Related]
7. Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment.
Uemura H; Chang C
Endocrinology; 1998 May; 139(5):2329-34. PubMed ID: 9564841
[TBL] [Abstract][Full Text] [Related]
8. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
Hu H; Jiang C; Ip C; Rustum YM; Lü J
Clin Cancer Res; 2005 Mar; 11(6):2379-88. PubMed ID: 15788689
[TBL] [Abstract][Full Text] [Related]
9. Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase.
Sumitomo M; Asano T; Asakuma J; Asano T; Nanus DM; Hayakawa M
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):260-6. PubMed ID: 14734478
[TBL] [Abstract][Full Text] [Related]
10. Androgen sensitivity related proteins in hormone-sensitive and hormone-insensitive prostate cancer cell lines treated by androgen antagonist bicalutamide.
Madarová J; Lukesová M; Hlobilková A; Riháková P; Murray PG; Student V; Vojtsek B; Kolár Z
Neoplasma; 2001; 48(5):419-24. PubMed ID: 11845989
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptides bombesin and calcitonin inhibit apoptosis-related elemental changes in prostate carcinoma cell lines.
Salido M; Vilches J; López A; Roomans GM
Cancer; 2002 Jan; 94(2):368-77. PubMed ID: 11900223
[TBL] [Abstract][Full Text] [Related]
12. Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.
Mimeault M; Venkatraman G; Johansson SL; Moore E; Henichart JP; Depreux P; Lin MF; Batra SK
Int J Cancer; 2007 Jan; 120(1):160-9. PubMed ID: 17013895
[TBL] [Abstract][Full Text] [Related]
13. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
Engedal N; Korkmaz CG; Saatcioglu F
Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Elemental Patterns of Apoptosis Resistance in Transdifferentiated Androgen-Dependent Prostatic Carcinoma Cells.
Salido M; Vilches J
Microsc Microanal; 2016 Aug; 22(4):865-77. PubMed ID: 27487730
[TBL] [Abstract][Full Text] [Related]
15. Heat-shock proteins inhibit induction of prostate cancer cell apoptosis.
Gibbons NB; Watson RW; Coffey RN; Brady HP; Fitzpatrick JM
Prostate; 2000 Sep; 45(1):58-65. PubMed ID: 10960843
[TBL] [Abstract][Full Text] [Related]
16. Etoposide induces growth arrest and disrupts androgen receptor signaling in prostate cancer cells.
Liu S; Yamauchi H
Oncol Rep; 2010 Jan; 23(1):165-70. PubMed ID: 19956877
[TBL] [Abstract][Full Text] [Related]
17. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
Zhang M; Latham DE; Delaney MA; Chakravarti A
Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703
[TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
19. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines.
Hsieh TC; Wu JM
Exp Cell Res; 1999 May; 249(1):109-15. PubMed ID: 10328958
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis of androgen-independent mammary and prostate cell lines induced by topoisomerase inhibitors: common pathway of gene regulation.
Furuya Y; Ohta S; Ito H
Anticancer Res; 1997; 17(3C):2089-93. PubMed ID: 9216669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
